Academic Journal
Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the Omicron era: A prospective cohort study
| العنوان: | Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the Omicron era: A prospective cohort study |
|---|---|
| المؤلفون: | Calderón-Parra, Jorge, Gutiérrez-Villanueva, Andrea, Ronda-Roca, Gerard, Jimenez, Maria Luisa Martín, de la Torre, Helena, Ródenas-Baquero, María, Paniura-Pinedo, María, Lozano-Llano, Carla, Pintos-Pascual, Ilduara, Fernández-Cruz, Ana, Ramos-Martínez, Antonio, Muñez-Rubio, Elena |
| المصدر: | International Journal of Antimicrobial Agents ; volume 63, issue 3, page 107095 ; ISSN 0924-8579 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2024 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.ijantimicag.2024.107095 |
| الاتاحة: | http://dx.doi.org/10.1016/j.ijantimicag.2024.107095 https://api.elsevier.com/content/article/PII:S092485792400013X?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S092485792400013X?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| رقم الانضمام: | edsbas.AC42A1D0 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.ijantimicag.2024.107095 |
|---|